🇺🇸 FDA

Intelligence · Clinical Pipeline

Hospital Authority Pipeline

All ClinicalTrials.gov programs at Hospital Authority — phase, modality, and trial IDs.

Programs
60

Quick answer

Hospital Authority has 60 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. 3 % Minoxidil lotion

    Hospital Authority, Hong Kong

    Beard Enhancement

    approved small molecule completed

    1 trial

  2. 6-month clopidogrel therapy

    Hospital Authority, Hong Kong

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  3. Alendronate

    Hospital Authority, Hong Kong

    Non-Traumatic Osteonecrosis

    approved small molecule active

    1 trial

  4. Allopurinol Tablet 300 mg

    Hospital Authority, Hong Kong

    Kidney Calculi

    approved small molecule completed

    1 trial

  5. Aripiprazole

    Hospital Authority, Hong Kong

    First Episode Psychosis

    approved small molecule completed

    1 trial

  6. Bismuth-based susceptibility-guided treatment

    Hospital Authority, Hong Kong

    Helicobacter Pylori

    approved small molecule completed

    1 trial

  7. Breeze2 glucometer

    Hospital Authority, Hong Kong

    Diabetes

    approved other active

    1 trial

  8. Bupivacaine

    Hospital Authority, Hong Kong

    Pain

    approved small molecule completed

    1 trial

  9. Byfavo

    Hospital Authority, Hong Kong

    Bronchoscopy

    approved small molecule completed

    1 trial

  10. Chlorhexidine gluconate

    Hospital Authority, Hong Kong

    Liver Tumors

    approved small molecule completed

    1 trial

  11. Combination Cinacalcet with Vitamin D analogue

    Hospital Authority, Hong Kong

    Secondary Hyperparathyroidism

    approved small molecule active

    1 trial

  12. Continuos epidural infusion

    Hospital Authority, Hong Kong

    Analgesia, Epidural

    approved other active

    1 trial

  13. Cook balloon uterine stent

    Hospital Authority, Hong Kong

    Intrauterine Adhesion

    approved other completed

    1 trial

  14. Dexamethasone and N-acetylcysteine (NAC)

    Hospital Authority, Hong Kong

    Carbon Monoxide Poisoning

    approved small molecule active

    1 trial

  15. Dexmedetomidine

    Hospital Authority, Hong Kong

    Thyroid Diseases

    approved small molecule active

    1 trial

  16. Dextrose 5%

    Hospital Authority, Hong Kong

    End-Stage Kidney Disease

    approved small molecule active

    1 trial

  17. Etomidate

    Hospital Authority, Hong Kong

    Choledocholithiasis

    approved small molecule completed

    1 trial

  18. Finerenone

    Hospital Authority, Hong Kong

    Heart Failure and Preserved Ejection Fraction

    approved small molecule active

    1 trial

  19. Forsteo

    Hospital Authority, Hong Kong

    Spine Deformity

    approved small molecule active

    1 trial

  20. Group C : Saline + propofol group

    Hospital Authority, Hong Kong

    Urologic Surgery

    approved small molecule completed

    1 trial

  21. Intraosseous

    Hospital Authority, Hong Kong

    Cardiac Arrest

    approved other completed

    1 trial

  22. Intraosseous Morphine

    Hospital Authority, Hong Kong

    Pain Postoperative

    approved other active

    1 trial

  23. Ixekizumab

    Hospital Authority, Hong Kong

    Plaque Psoriasis

    approved mab active

    1 trial

  24. LNG-IUS

    Hospital Authority, Hong Kong

    Endometriosis

    approved small molecule completed

    1 trial

  25. Levofloxacin

    Hospital Authority, Hong Kong

    Urinary Tract Infection

    approved small molecule active

    1 trial

  26. Lucentis

    Hospital Authority, Hong Kong

    Wet Macular Degeneration

    approved small molecule completed

    1 trial

  27. Methotrexate plus sulfasalazine

    Hospital Authority, Hong Kong

    Rheumatoid Arthritis

    approved small molecule terminated

    1 trial

  28. Metronidazole

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  29. MgSO4 plus Ropivacaine

    Hospital Authority, Hong Kong

    Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block

    approved small molecule completed

    1 trial

  30. Minoxidil lotion 1%

    Hospital Authority, Hong Kong

    Eyebrow Hypotrichosis

    approved small molecule completed

    1 trial

  31. Minoxidil lotion 2%

    Hospital Authority, Hong Kong

    Hypotrichosis of Eyebrows

    approved small molecule completed

    1 trial

  32. Moxonidine 0.2 MG

    Hospital Authority, Hong Kong

    Central Sympathetic Nervous System Diseases

    approved small molecule completed

    1 trial

  33. Oral prednisolone (30mg/day) for 28 days

    Hospital Authority, Hong Kong

    Esophageal Neoplasms

    approved small molecule active

    1 trial

  34. Oxycodone

    Hospital Authority, Hong Kong

    Postcraniotomy Pain

    approved small molecule completed

    1 trial

  35. Paliperidone ER

    Hospital Authority, Hong Kong

    Schizophrenia

    approved small molecule completed

    1 trial

  36. Remifentanil

    Hospital Authority, Hong Kong

    Labor Pain

    approved small molecule active

    1 trial

  37. Renin-angiotensin system blockers

    Hospital Authority, Hong Kong

    Diabetes

    approved small molecule active

    1 trial

  38. Rifaximin Oral Tablet

    Hospital Authority, Hong Kong

    Irritable Bowel Syndrome With Diarrhea

    approved small molecule completed

    1 trial

  39. Rosuvastatin

    Hospital Authority, Hong Kong

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial

  40. SGLT2 inhibitor (Empagliflozin 25 MG)

    Hospital Authority, Hong Kong

    Type2 Diabetes

    approved small molecule active

    1 trial

  41. SYSTANE™ Hydration Lubricant Eye Drops

    Hospital Authority, Hong Kong

    Dry Eye Syndromes

    approved small molecule active

    1 trial

  42. Simethicone

    Hospital Authority, Hong Kong

    Colonoscopy

    approved small molecule completed

    1 trial

  43. Simvastatin

    Hospital Authority, Hong Kong

    Obesity

    approved small molecule active

    1 trial

  44. Topical Anesthetic

    Hospital Authority, Hong Kong

    Radial Artery Spasm

    approved small molecule active

    1 trial

  45. Transepicardial with Transseptal CD 133+ Implantation

    Hospital Authority, Hong Kong

    Coronary Artery Disease

    approved mab completed

    1 trial

  46. Trimebutine 100 MG

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  47. Valproic acid

    Hospital Authority, Hong Kong

    Drug Resistant Epilepsy

    approved small molecule active

    1 trial

  48. Vemlidy

    Hospital Authority, Hong Kong

    Chronic Hepatitis b

    approved small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does Hospital Authority have?

60 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.